Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,378 across all filing types
Latest filing 2019-02-25 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions, including committee memberships. It does not contain financial data, earnings, or report content. It is an announcement related to the company's board structure and management roles. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming it is not a full report or other filing type.
2019-02-25 English
GLOBAL OFFERING
Share Issue/Capital Change Classification · 95% confidence The document is an announcement of IPO allotment results for CStone Pharmaceuticals. It provides links to various PDF files containing the specific results of share applications (White/Yellow forms, eIPO). Since this document serves as the official notification and distribution point for the IPO allotment results, it falls under the category of share issuance and capital changes.
2019-02-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2019-02-21 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2019-02-21 English
GREEN APPLICATION FORM
Capital/Financing Update Classification · 95% confidence The document is an application form for the Hong Kong Public Offering of shares of CStone Pharmaceuticals, specifically a White Form eIPO Service Provider Application Form. It contains detailed instructions and terms for applying for shares in the IPO, including legal disclaimers, offer details, and procedural information. It is not a financial report, earnings release, or management discussion. It is also not an announcement of voting results, board changes, or legal proceedings. The document is related to capital raising through a public offering of shares, which fits the category of Capital/Financing Update (CAP). The document is substantive and not merely an announcement or a brief notice, and it is not a regulatory filing or report publication announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-02-14 English
YELLOW APPLICATION FORM
Share Issue/Capital Change Classification · 95% confidence The document is an application form related to the issuance and subscription of Hong Kong Offer Shares for CStone Pharmaceuticals, referencing the company's prospectus dated February 14, 2019. It includes detailed instructions for investors on how to apply for shares, declarations by applicants, and information about where to obtain printed prospectuses. The content is typical of a share issuance or capital raising process, specifically an IPO or share offer. There is no financial performance data, management discussion, audit information, or regulatory certification. The document is not a report but an application form for share subscription, which aligns with announcements or filings related to share issuance or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is substantial and contains detailed procedural content, supporting a high confidence in this classification.
2019-02-13 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.